Moriwaki, Toshikazu <br/><br/>
Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer.  [electronic resource] 

 -  Journal of hepato-biliary-pancreatic sciences  Sep 2015 
 - 669-74 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1868-6982 
<br/><br/><label>Standard No.: </label>10.1002/jhbp.255  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Biliary Tract Neoplasms--diagnosis<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Combinations<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Japan--epidemiology<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Oxonic Acid--administration & dosage<br/>Retrospective Studies<br/>Survival Rate--trends<br/>Tegafur--administration & dosage<br/>Treatment Outcome<br/>Gemcitabine